What is the latest SAIPARENT stock price?
The latest stored price for SAIPARENT is Rs 510.75 as of 2026-09-18.
gimli
SAIPARENT stock AI analysis
SAIPARENT Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
SAI PARENTERALS LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available SAIPARENT price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹510.75
1W return
-2.26%
1M return
-5.77%
3M return
-12.57%
6M return
n/a
1Y return
n/a
Market cap
₹2,256.45 cr
PE
114.95
PB
18.25
ROE
+19.63%
ROCE
+16.99%
RSI
40.45
Turnover
₹1.75 cr
Why it can matter in screens
- Momentum: SAIPARENT is below 50DMA, below 200DMA; RSI is 40.45.
- Returns: 1D +0.10%, 1W -2.26%, 1M -5.77%, 3M -12.57%, 1Y n/a.
- Trend levels: 52W high ₹706.00, 52W low ₹471.25, off high -27.66%.
- Liquidity: latest turnover is ₹1.75 cr; volume vs 20D is +0.32%.
- Valuation/profitability: PE 114.95, PB 18.25, ROE +19.63%, ROCE +16.99%.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Quick Answers
Is SAIPARENT above its 50DMA and 200DMA?
SAIPARENT is below 50DMA, below 200DMA. The latest 50DMA is 541.82 and the latest 200DMA is n/a.
What are SAIPARENT PE, ROE and ROCE?
SAIPARENT has PE 114.95, ROE +19.63%, and ROCE +16.99% in Gimli's latest available snapshot.
How has SAIPARENT performed recently?
SAIPARENT has returned -5.77% over 1 month, -12.57% over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
No recent data available.
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-03-31 | 494.96 cr | 54.35 cr | 19.63 cr | 4.44 |
| 2024-03-31 | 153.76 cr | 33.10 cr | 8.41 cr | 1.90 |
| 2023-03-31 | 96.80 cr | 18.77 cr | 4.38 cr | 0.99 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2025-03-31 | 723.58 cr | 8.15 cr | 203.66 cr | 123.61 cr |
| 2024-03-31 | 268.10 cr | 4.38 cr | 118.78 cr | 76.40 cr |
| 2023-03-31 | 133.96 cr | 0.17 cr | 68.55 cr | 31.48 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2025-03-31 | 33.15 cr | 32.65 cr | n/a |
| 2024-03-31 | -29.76 cr | -73.86 cr | n/a |
| 2023-03-31 | -12.80 cr | -30.14 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +51.16% | +4.03% | +8.53% | +0.98% | +36.29% | +0.00% |
| 2026-04-01 | +51.16% | +5.73% | +12.86% | +3.81% | +30.26% | +0.00% |
| 2026-03-31 | +51.16% | +5.73% | +12.86% | +3.81% | +30.26% | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 440,829.82 cr | 36.388220 | +15.50% | +11.45% |
| DIVISLAB | DIVI S LABORATORIES LTD | 248,876.81 cr | 85.407280 | +18.37% | +53.39% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 163,807.57 cr | 75.106636 | +17.33% | +35.67% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,608.22 cr | 65.670049 | +21.03% | +13.94% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 116,723.14 cr | 26.011308 | +16.04% | +10.70% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 33.401961 | +10.25% | -11.64% |
| LAURUSLABS | LAURUS LABS LIMITED | 105,487.98 cr | 96.587446 | +21.77% | +111.64% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 102,122.47 cr | 70.799892 | +14.33% | -10.58% |
Try these prompts
- Analyze SAI PARENTERALS with valuation, momentum and industry peers
- Compare SAIPARENT with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare SAIPARENT with other Healthcare stocks
Data snapshot: 2026-09-18. Not investment advice.